Abstract: A vapor delivery system having: a) a base unit configured to generate a supply of vapor; and b) a vapor control system configured to allow a user to selectively: a) cause vapor generated by the base unit to be discharged primarily to a surrounding space within which the base unit resides to thereby increase vapor density in the surrounding space; and b) cause vapor generated by the base unit to be discharged primarily to a vapor guide structure configured to: i) be placed operatively with respect to a user's face; and ii) guide discharging vapor generated by the base unit into at least one of the user's nose and mouth with the vapor guide structure placed operatively with respect to the user's face.

Abstract: The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof: Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.

Abstract: The combination of: a) an apparatus with a main body and an operating assembly on the main body configured to cause fluid from a supply to be processed so as to become entrained in air in a surrounding atmosphere, wherein the main body has an elongate finger having a length and a free end; and b) a container defining a receptacle for a supply of fluid. The container has an entry opening that is dimensioned to allow the elongate finger on the main body to be directed, free end first, through the entry opening to allow a portion of the length of the elongate finger to be immersed in a supply of fluid in the receptacle. Structure cooperates between the apparatus and container to support the main body and container in an operative relationship.

Abstract: The present teachings provide a compound represented by the following structural formula: (Formula (I)); or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.

Abstract: The present invention is directed to novel synthetic methods for preparing cyclopropyl indolinone compound represented by Structural Formula (A): (A) or its pharmaceutically acceptable salt thereof. Also included are synthetic intermediates described herein.

Abstract: The present invention relates to a prediction system for short-term solar irradiance and the method for operating the same. A total sky imager is adopted for acquiring sky images. After imaging, the images are operated for calculating the shading value of sunlight according to the sky images. Then, according to the shading values of sunlight for different times, the trend value for power generation can be calculated. According to the trend value of power generation, whether to start other power sources via power deployment in the near future can be determined and thus maintaining the stability of the overall power grid.

Abstract: A heat dissipation simulator of a component on a printed circuit board (PCB) includes a simulation board and a simulated heat source. The simulation board includes an iron layer and a plastic layer. The simulated heat source includes a simulation chip, a thermal, and a heat sink. The simulation chip, the thermal piece, and the heat sink are mounted on the simulation board in that order. The heat dissipation simulator replaces a sample of the PCB with the component for simulating working states of the component on the PCB.

Abstract: A system for controlling key access using a phone and internet-connected key box device. The key box device hangs or mounts on a fixture and controls key access to visitors. Visitors may unlock a chamber in a key device for key access by calling the phone number on the key box device display and passing an authentication process during a scheduled time. The key box device owner may monitor and remotely control access to the key box and its key chamber via a software application on cloud computing services that interfaces with operations programmed into a circuit board in the key box device.

Abstract: The present invention is directed to novel synthetic methods for preparing cyclopropyl indolinone compound represented by Structural Formula (A): (A) or its pharmaceutically acceptable salt thereof. Also included are synthetic intermediates described herein.

Abstract: The present teachings provide a compound represented by structural formula (I-0), or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.

Abstract: A wireless BCI input system for mobile intelligent devices is described. The system may include an SSVEP keyboard for stimulating SSVEP signals and an EEG headband for acquiring EEG signals. The SSVEP keyboard may include sixteen virtual buttons and a mask that can be replaced to change functions of the virtual buttons. The EEG headband may include an EEG acquisition module, an EEG analysis module, and a Bluetooth communication module, which are used for acquiring EEG signals, determining the user's input intentions, and sending characters or controlling commands to a matched mobile intelligent device via Bluetooth connection.

Abstract: The present teachings provide a compound represented by the following structural formula: (Formula (I)); or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.

Abstract: The present invention relates to a prediction system for short-term solar irradiance and the method for operating the same. A total sky imager is adopted for acquiring sky images. After imaging, the images are operated for calculating the shading value of sunlight according to the sky images. Then, according to the shading values of sunlight for different times, the trend value for power generation can be calculated. According to the trend value of power generation, whether to start other power sources via power deployment in the near future can be determined and thus maintaining the stability of the overall power grid.

Abstract: Multiple schemes and techniques for facilitating presentations with an interactive application are described. For example, an interactive application provides a console view overlay for integrating multiple productivity applications into a graphical user interface (GUI) window. An interactive application can also share a selected display portion of the console view overlay with other interactive applications. As another example, presenters and other audience members can draw on the selected display portion being shared, and the drawn graphics are synchronously displayed by the other interactive applications. Interactive applications, as directed by their users, can join various member groups and specific presentations thereof. Moreover, a user may share content in accordance with membership grouping.

Abstract: Multiple schemes and techniques for facilitating presentations with an interactive application are described. For example, an interactive application provides a console view overlay for integrating multiple productivity applications into a graphical user interface (GUI) window. An interactive application can also share a selected display portion of the console view overlay with other interactive applications. As another example, presenters and other audience members can draw on the selected display portion being shared, and the drawn graphics are synchronously displayed by the other interactive applications. Interactive applications, as directed by their users, can join various member groups and specific presentations thereof. Moreover, a user may share content in accordance with membership grouping.

Abstract: The present teaching provide indazole compounds represented by Structural Formulae (I) or (I?) or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof as protein kinase inhibitors, such as TTK protein kinase, polo-like kinase 4 (PLK4) and Aurora kinases having anticancer activity against breast cancer cells, colon cancer cells, and ovarian cancer cells.

Abstract: The present invention is directed to novel synthetic methods for preparing a spiro cyclopropyl indolinone compound represented by Structural Formula (A): or its pharmaceutically acceptable salt thereof. Also included are synthetic intermediates described herein.

Abstract: The present teachings provide a compound represented by structural formula (1-0), or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.

Abstract: Electropolymerized polymer or copolymer films on a conducting substrate (e.g., graphene) and methods of making such films. The films may be part of multilayer structures. The films can be formed by anodic or cathodic electropolymerization of monomers. The films and structures (e.g., multilayer structures) can be used in devices such as, for example, electrochromic devices, electrical-energy storage devices, photo-voltaic devices, field-effect transistor devices, electrical devices, electronic devices, energy-generation devices, and microfluidic devices.

Abstract: An electronic system includes an electronic component, a heat dissipation device coupled on the electronic component and a retaining device around the electronic component. The heat dissipation device includes a base configured to contact the electronic component and a plurality of fins extending from the base. The base includes a coupling face forming a plurality of screw threads thereon. The retaining device includes at least a coupling face. The coupling face of the retaining device forms a plurality of screw threads for engaging with the screw threads of the coupling face of the base.